AVX
Avexa
- Short interest
- 0.28%
- +0.25 pp 30d
- as of 23 Oct 2015
- Reported shorts
- 2.7M
- Shares on issue
- 980.779M
Avexa (AVX) company profile
Profile, insiders and operations
Company
AI-generated research profile of Avexa
ASX Listed
Biotechnology
Pharmaceuticals
Healthcare
Research & Development
Information regarding Avexa's specific business model, market position, and unique value proposition is currently unavailable due to the absence of a company website and detailed public summaries. The company's operational focus and strategic direction cannot be determined from the provided context.
AVX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required